SpithovenE.M., KramerA., MeijerE.. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.Kidney Int2014; 86(6): 1244–1252.
3.
BajwaZ.H., SialK.A., MalikA.B., SteinmanT.I.. Pain patterns in patients with polycystic kidney disease.Kidney Int2004; 66: 1561–1569.
4.
OberdhanD.. Patient-reported pain in autosomal dominant polycystic kidney disease: initial concepts based on patient focus group discussions [Abs SA-PO283].J Am Soc Nephrol2013; 24 Abs Suppl: 692.
5.
OberdahnD.. Patient experience with pain related to autosomal dominant polycystic kidney disease (ADPKD) [Abs PUB285].J Am Soc Nephrol2014; 25 Abs Suppl: 960.
6.
MiskulinD.C., AbebeK.Z., ChapmanA.B.. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD Stages 1–4: a cross-sectional study.Am J Kidney Dis2014; 63: 214–226.
7.
HeiweS., BjukeM.. “An evil heritage”: interview study of pain and autosomal dominant polycystic kidney disease.Pain Manag Nurs2009; 10: 134–141.
8.
CasteleijnN.F., VisserF.W., DrenthJ.P.. A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.Nephrol Dial Transplant2014; 29(Suppl 4): iv142–153.
9.
ShawC., SimmsR.J., PitcherD., SandfordR.. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.Nephrol Dial Transplant2014; 29: 1910–1918.
10.
SpithovenE.M.. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry.Nephrol Dial Transplant2014; 29(Suppl 4): iv15–iv25.
11.
WijnandsT.F., NeijenhuisM.K., KievitW.. Evaluating health-related quality of life in patients with polycystic liver disease and determining the impactof symptoms and liver volume.Liver Int2014; 34: 1578–1583.
12.
de BarrosB.P., NishiuraJ.L., HeilbergI.P., KirsztajnG.M.. Anxiety, depression, and quality of life in patients with familial glomerulonephritis or autosomal dominantpolycystic kidney disease.J Bras Nefrol2011; 33: 120–128.
